Tissue Engineering von Fettgewebe mittels bioabbaubaren Biomaterialien zur Weichteildefektdeckung

Zusammenfassung

Bestehende Weichteildefekte nach Unfallverletzungen, onkologischen Tumorresektionen, kongenitalen Anomalien oder chronischen Wunden stellen eine zentrale Herausforderung in der rekonstruktiven Chirurgie dar. Der derzeitige Goldstandard in der Therapie von Gewebedefekten besteht in der Gewebetrans plantation in Form von freien oder lokalen Lappenplastiken. Limitierend ist jedoch die unumgängliche Morbidität an der Spenderstelle nach dem Gewebetransfer. Vor diesem Hintergrund wurden in den letzten Jahren aufgrund der günstigen Gewebetextur und hohen Plastizität große Anstrengungen im Bereich des Tissue Engineerings von vaskularisierten, langzeitstabilen autologen Fettgewebskonstrukten unternommen. Dabei stellt der enge Zusammenhang von Adipogenese und Angiogenese eine entscheidende Hürde in der de novo Erzeugung von Fettgewebe dar. Eine besondere Rolle kommt hierbei bioabbaubaren Biomaterialien (Scaffolds) als Trägereinheiten für Zellen und der damit verbundenen Zell-Matrix-Interaktion zu. Ein ideales Biomaterial sollte die Zellproliferation, -adhäsion und -differenzierung unterstützen, und gleichzeitig unbedenklich in seiner Biokompatibilität sein. Die vorliegende Übersichtsarbeit gewährt einen Überblick über derzeitige Ansätze des Tissue Engineerings von Fettgewebe vor dem Hintergrund der aktuell verfügbaren Evidenz.

Die Problematiken bisheriger Modelle sind einerseits hohe Resorptionsraten der gezüchteten Gewebekonstrukte und andererseits der fehlende Nachweis von klinisch relevanten Gewebevolumina. Das Tissue Engineering von Fettgewebe in einem Wachtumskammermodell in Kombination mit Scaffolds bietet eine weitere Möglichkeit zur in vivo Gewebezüchtung. Hier zeigen aktuelle Ergebnisse, dass eine de novo Fettgewebezüchtung mit klinisch relevanten und langzeitstabilen Volumina in vivo möglich ist. Dieses Modell besitzt, unserer Auffassung nach, das Potential die Therapie großer Weichteildefekte signifikant zu verbessern.

Abstract

Soft tissue defects resulting from injuries, tumor resection, congenital anomalies or chronic wounds pose a great challenge to reconstructive surgery. The current gold standard in therapy of such defects is the tissue transplantation in terms of free or local flaps. Unfortunately, donor site morbidity remains a considerable risk of flap surgery. Therefore, tissue engineering of autologous vascularized long term stable adipose tissue constructs could enrich the therapeutic possibilities of soft tissue defects. De novo adipose tissue growing requires fundamental knowledge about this kind of tissue and its synthesis, closely linked to angiogenesis. Bioresorbable biomaterials (scaffolds) are of crucial importance for adipose tissue engineering. Simulation or replacement of extracellular matrix for tissue growth by scaffold application requires a profound understanding of cell-matrix interactions. A proper biomaterial should be capable of supporting cell adherence, proliferation and differentiation. Important features are biocompatibility and resorption without toxic metabolites. In this review, various scaffold materials are discussed and novel achievements are presented. Persisting problems of de novo adipose tissue formation are high resorption rates and small tissue volumes of adipose constructs. Adipose tissue formation in a tissue engineering chamber is an additional possibility for in vivo tissue engineering. Recent studies proof that long term stable de novo adipose tissue formation of clinically relevant tissue volumes is possible. This method, in our opinion, has the potential to improve therapeutic strategies of soft tissue defects significantly.

Schlüsselwörter

Tissue engineering - Biomaterialien - Fettgewebe - Weichteildefekt - Rekonstruktive Chirurgie

Key words

tissue engineering - biomaterials - adipose tissue - soft tissue defect - reconstructive surgery

Fußnote

^* S. Klein und T. Aung haben beide zu gleichen Teilen beigetragen

• Literatur

• 1 Gooden MA, Gentile AT, Mills JL. et al. Free tissue transfer to extend the limits of limb salvage for lower extremity tissue loss. Am. J. Surg 1997; 174: 644-8 discussion 648–9
• 2 Patrick CW. Tissue engineering strategies for adipose tissue repair. Anat. Rec 2001; 263: 361-366
• 3 Pallua N, Magnus Noah E. The tunneled supraclavicular island flap: an optimized technique for head and neck reconstruction. Plast. Reconstr. Surg 2000; 105: 842-51 discussion 852–4
• 4 Czerny V. Plastischer Ersatz der Brustdrüse durch ein Lipom Zentralbl Chir. 1895 27. 72
• 5 Beahm EK, Walton RL, Patrick CW. Progress in adipose tissue construct development. Clin Plast Surg 2003; 30: 547-58 viii
• 6 Neuber G. Fetttransplantation. Verhandlungen der Deutschen Gesellschaft für Chirurgie. 1893 22. 66
• 7 Prantl L.. et al. Aktuelle Erkenntnisse zur Eigenfett Transplantation anhand der neue Leitlinie „Autologe Fetttransplantation“. Handchirurgie· Mikrochirurgie· Plastische Chirurgie 2016; 48 (06) 330-336
• 8 Walton RL, Beahm EK, Wu L. De novo adipose formation in a vascularized engineered construct. Microsurgery 2004; 24: 378-384
• 9 Hahn P, Novak M. Development of brown and white adipose tissue. J. Lipid Res 1975; 16: 79-91
• 10 Wu J, Boström P, Sparks LM. et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012; 150: 366-376
• 11 Trayhurn P, Wood IS . . Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr 2004; 92: 347-355
• 12 Cao Y. Angiogenesis modulates adipogenesis and obesity. J. Clin. Invest 2007; 117: 2362-2368
• 13 Dolderer JH, Medved F, Haas RM. et al. Angiogenese und Vaskularisation beim Tissue Engineering von Fettgewebe. Handchir Mikrochir Plast Chir 2013; 45: 99-107
• 14 Nakajima I, Yamaguchi T, Ozutsumi K. et al. Adipose tissue extracellular matrix: newly organized by adipocytes during differentiation. Differentiation 1998; 63: 193-200
• 15 Tang W, Zeve D, Suh JM. et al. White fat progenitor cells reside in the adipose vasculature. Science 2008; 322: 583-586
• 16 Rosen ED, MacDougald OA. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol 2006; 7: 885-896
• 17 Crandall DL, Hausman GJ, Kral JG. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 1997; 4: 211-232
• 18 Hausman GJ, Kauffman RG. The histology of developing porcine adipose tissue. J. Anim. Sci. 1986; 63: 642-658
• 19 Carmeliet P. Angiogenesis in health and disease. Nat. Med 2003; 9: 653-660
• 20 Jain RK. Molecular regulation of vessel maturation. Nat. Med. 2003; 9: 685-693
• 21 von Heimburg D, Zachariah S, Heschel I. et al. Human preadipocytes seeded on freeze-dried collagen scaffolds investigated in vitro and in vivo. Biomaterials 2001; 22: 429-438
• 22 Kaewsuwan S, Song SY, Kim JH. et al. Mimicking the functional niche of adipose-derived stem cells for regenerative medicine. Expert Opin Biol Ther 2012; 12: 1575-1588
• 23 Walton RL, Beahm EK, Wu L. De novo adipose formation in a vascularized engineered construct. Microsurgery 2004; 24: 378-384
• 24 Tabata Y, Miyao M, Inamoto T. et al. De novo formation of adipose tissue by controlled release of basic fibroblast growth factor. Tissue Eng 2000; 6: 279-289
• 25 Yuksel E, Weinfeld AB, Cleek R. et al. Augmentation of adipofascial flaps using the long-term local delivery of insulin and insulin-like growth factor-1. Plast. Reconstr. Surg 2000; 106: 373-382
• 26 Katz AJ, Llull R, Hedrick MH. et al. Emerging approaches to the tissue engineering of fat. Clin Plast Surg 1999; 26: 587-603 viii
• 27 Yuksel E, Weinfeld AB, Cleek R. et al. Increased free fat-graft survival with the long-term, local delivery of insulin, insulin-like growth factor-I, and basic fibroblast growth factor by PLGA/PEG microspheres. Plast. Reconstr. Surg 2000; 105: 1712-1720
• 28 Cao Y, Mitchell G, Messina A. et al. The influence of architecture on degradation and tissue ingrowth into three-dimensional poly(lactic-co-glycolic acid) scaffolds in vitro and in vivo. Biomaterials 2006; 27: 2854-2864
• 29 Lavik E, Langer R. Tissue engineering: current state and perspectives. Appl. Microbiol. Biotechnol 2004; 65: 1-8
• 30 Hernández A, Reyes R, Sánchez E. et al. In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system. J Biomed Mater Res A 2012; 100: 2382-2391
• 31 Weiser B, Prantl L, Schubert TEO. et al. In vivo development and long-term survival of engineered adipose tissue depend on in vitro precultivation strategy. Tissue Eng Part A 2008; 14: 275-284
• 32 Zhou C, Shi Q, Guo W. et al. Electrospun bio-nanocomposite scaffolds for bone tissue engineering by cellulose nanocrystals reinforcing maleic anhydride grafted PLA. ACS Appl Mater Interfaces 2013; 5: 3847-3854
• 33 Wiggenhauser PS, Müller DF, Melchels FPW. et al. Engineering of vascularized adipose constructs. Cell Tissue Res 2012; 347: 747-757
• 34 Kral JG, Crandall DL. Development of a human adipocyte synthetic polymer scaffold. Plast. Reconstr. Surg 1999; 104: 1732-1738
• 35 Patel PN, Gobin AS, West JL. et al. Poly(ethylene glycol) hydrogel system supports preadipocyte viability, adhesion, and proliferation. Tissue Eng 2005; 11: 1498-1505
• 36 Stosich MS, Mao JJ. Adipose tissue engineering from human adult stem cells: clinical implications in plastic and reconstructive surgery. Plast. Reconstr. Surg 2007; 119: 71-83 discussion 84–5
• 37 Choi YC, Choi JS, Kim BS. et al. Decellularized Extracellular Matrix Derived from Porcine Adipose Tissue as a Xenogeneic Biomaterial for Tissue Engineering. Tissue engineering. Part C, Methods. 2012
• 38 Flynn LE, Prestwich GD, Semple JL. et al. Proliferation and differentiation of adipose-derived stem cells on naturally derived scaffolds. Biomaterials 2008; 29: 1862-1871
• 39 Kawaguchi N, Toriyama K, Nicodemou-Lena E. et al. De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. Proc. Natl. Acad. Sci. U.S.A. 1998; 95: 1062-1066
• 40 Cronin KJ, Messina A, Knight KR. et al. New murine model of spontaneous autologous tissue engineering, combining an arteriovenous pedicle with matrix materials. Plast. Reconstr. Surg 2004; 113: 260-269
• 41 Ito R, Morimoto N, Liem PH. et al. Adipogenesis using human adipose tissue-derived stromal cells combined with a collagen/gelatin sponge sustaining release of basic fibroblast growth factor. J Tissue Eng Regen Med 2014; 8: 1000-1008
• 42 Torio-Padron N, Baerlecken N, Momeni A. et al. Engineering of adipose tissue by injection of human preadipocytes in fibrin. Aesthetic Plast Surg 2007; 31: 285-293
• 43 Sengupta D, Heilshorn SC. Protein-engineered biomaterials: highly tunable tissue engineering scaffolds. Tissue Eng Part B Rev 2010; 16: 285-293
• 44 Kang JH, Gimble JM, Kaplan DL. In vitro 3D model for human vascularized adipose tissue. Tissue Eng Part A 2009; 15: 2227-2236
• 45 Jing W, Lin Y, Wu L. et al. Ectopic adipogenesis of preconditioned adipose-derived stromal cells in an alginate system. Cell Tissue Res 2007; 330: 567-572
• 46 Hemmrich K, Heimburg D von, Rendchen R. et al. Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice to evaluate potential for soft tissue engineering. Biomaterials 2005; 26: 7025-7037
• 47 Baluk P, McDonald DM. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann. N. Y. Acad. Sci 2008; 1131: 1-12
• 48 Tanaka Y, Sung K, Tsutsumi A. et al. Tissue engineering skin flaps: which vascular carrier, arteriovenous shunt loop or arteriovenous bundle, has more potential for angiogenesis and tissue generation?. Plast. Reconstr. Surg 2003; 112: 1636-1644
• 49 Dolderer JH, Kehrer A, Schiller SM. et al. De-novo Generierung von vaskularisiertem Gewebe mittels unterschiedlicher Gefäßstielkonfigurationen in perforierten und geschlossenen Wachstumskammern. Wien Med Wochenschr 2010; 160: 139-146
• 50 Dolderer JH, Abberton KM, Thompson EW. et al. Spontaneous large volume adipose tissue generation from a vascularized pedicled fat flap inside a chamber space. Tissue Eng 2007; 13: 673-681
• 51 Lokmic Z, Stillaert F, Morrison WA. et al. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. FASEB J 2007; 21: 511-522
• 52 Ingber DE, Tensegrity I. Cell structure and hierarchical systems biology. J. Cell. Sci 2003; 116: 1157-1173
• 53 Findlay MW, Dolderer JH, Trost N. et al. Tissue-engineered breast reconstruction: bridging the gap toward large-volume tissue engineering in humans. Plast. Reconstr. Surg 2011; 128: 1206-1215
• 54 Arkudas A.. et al. Combination of extrinsic and intrinsic pathways significantly accelerates axial vascularization of bioartificial tissues. Plast Reconstr Surg 2012; 129 (01) 55e-65e
• 55 Weigand A.. et al. Acceleration of vascularized bone tissue-engineered constructs in a large animal model combining intrinsic and extrinsic vascularization. Tissue Engineering Part A 2015; 21 (09/10) 1680-1694
• 56 Dolderer JH, Thompson EW, Slavin P. et al. Long-term stability of adipose tissue generated from a vascularized pedicled fat flap inside a chamber. Plast. Reconstr. Surg 2011; 127: 2283-2292